Globocan là gì

Estimated age-standardized incidence rates (World) in 20trăng tròn, all cancers, both sexes, all ages. Datasource: Globocan 2020

IARC released on 14th December the updated Globocan 20trăng tròn with new estimates on the global cancer burden, indicating that it has risen to 19.3 million cases and 10 million cancer deaths in 20đôi mươi.

Bạn đang xem: Globocan là gì


What is GLOBOCAN?

GLOBOCAN 2020 is an online database providing global cancer statistics và estimates of incidence & mortality in 185 countries for 36 types of cancer, and for all cancer sites combined. The data is part of IARC’s Global Cancer Observatory, & is available online at Cancer Today with user-friendly facilities to produce maps and explore visualisations.


The International Agency for Retìm kiếm on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men & 1 in 11 women die from the disease. These new estimates suggest that more than 50 million people are living within five years of a past cancer diagnosis. Ageing populations globally và socio-economic risk factors remain amuốn the primary factors driving this increase.

Xem thêm:

Breast cancer represents 1 in 4 cancers diagnosed aao ước women globally. Colorectal, lung, cervical, & thyroid cancers are also comtháng amuốn women.

 

 


*

Lung cancer và prostate cancer are the most common amuốn men, together accounting for nearly one-third of all male cancers.

Xem thêm: Bank Routing Number Là Gì ? Mã Số Chuyển Aba » Kho Tri Thức Việt


*

 

Inequity in health care between higher và lower resourced settings

For the 1st time, female breast cancer has become the most commonly diagnosed cancer, surpassing lung cancer, in particular due to high prevalence in low- và middle-income countries (LMICs). Lung cancer remains the leading cause of cancer deaths, not only in many LMICs but also in most higher-income regions like North America, Europe & Australia. 

There continue lớn be significant disparities between higher & lower-income countries, with GLOBOCAN 2020 predicting that countries classified with "Low or Medium Human Development Index (HDI) "will have the greathử nghiệm relative sầu increases in #cancer incidence by 2040.


*

The need for more reliable national cancer data

IARC draws attention to lớn a situation of limited data in certain countries và emphasises the need for better cancer data registries:

"Caution must be exercised when interpreting these estimates, given the limited quality and coverage of cancer data worldwide at present, particularly in low- và middle-income countries. IARC’s approach is not only to evaluate, compile, and use the data from the Agency’s collaborators in these estimates but also to lớn work alongside national staff to lớn improve local data quality, registry coverage, và analytical capađô thị. The clear need for investment in population-based cancer registration in low- & middle-income countries led to the launch of the Global Initiative sầu for Cancer Registry Development (GICR), coordinated by IARC. The goal of the GICR is to lớn insize cancer control through defined improvements in the coverage, quality, & use of population-based cancer registration data worldwide."

For instance, the International Journal of Cancer reports in an article, "Progress, challenges and ways forward supporting cancer surveillance in Latin America", that less than 3% và 10% of the respective populations of Central America và South America are covered by high‐quality cancer registries. 

Effective sầu National Cancer Control Plans, a primary tool in the fight against cancer, rely on solid data registries. For more information on the IARC Regional Hubs for Cancer Registration, please visit the GICR webpage. 


Chuyên mục: Tổng Hợp